I am too, personally I feel all on them will be su
Post# of 148326
I've read some patients have gotten approval from their oncologist (and some insurance) for maraviroc, based on the phase 2 trial. I've read some oncologist have used a drug off-label approved for one cancer if there are positive animal studies in the other cancer. I can try to find links next week. But these 8 studies have some serious indications.
I also remember a poster on SA, not a shareholder, saying this will be the biggest mover, only several other companies had 8 approved phase 2 cancer trials, all over 10B in market cap. (I didn't double check this for accuracy, but I liked the sound of it.)